Tech Company Financing Transactions
Kite Pharma Funding Round
Private investors joined a $50 million funding round for Kite Pharma. This venture round was announced on 4/28/2014.
Transaction Overview
Company Name
Announced On
4/28/2014
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Kite expects to use proceeds of the financing to advance its programs developing novel cancer immunotherapy products. Kite's lead investigational therapy is an autologous eACT product that targets CD19 expression on B cell malignancies, including diffuse large B cell lymphoma (DLBCL). Additional programs will target a number of both hematological malignancies and solid tumors.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
2400 Bdwy.
Santa Monica, CA 90404
USA
Santa Monica, CA 90404
USA
Phone
Website
Email Address
Overview
Kite Pharma, Inc. (NASDAQ: KITE) is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arie Belldegrun
Chief Financial Officer
Cynthia Buttita
Chief Scientific Officer
Margo Roberts
VP - Bus. Development
Helen Kim
VP - R & D
David Chang
Browse more venture capital transactions:
Prev: 4/28/2014: Slack venture capital transaction
Next: 4/28/2014: Setem Technologies venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs